Merrion Biopharma Limited
Merrion is a specialty pharmaceutical company based upon proprietary technologies for oral drug delivery acquired from the Élan Corporation in 2003. It has multiple market-ready, advanced oral drug delivery technologies with several significant products already proven in human clinical trials.
In addition it has a research pipeline of novel tissue targeting drug delivery technologies providing future product solutions for the oral delivery of CNS drugs and vaccines. All of the technologies are underpinned with a comprehensive intellectual property portfolio. Merrion operates from a modern, fully operational facility including a state of the art cGMP manufacturing facility.

www.merrionpharma.com ->